Imc Chicago, LLC Biogen Inc. Transaction History

Imc Chicago, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$193.77 - $244.14 $1.98 Million - $2.5 Million	-10,222 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$223.92 - $287.77 $278,332 - $357,698	-1,243 Reduced 10.84%	10,222 $2.45 Million
Q3 2021 Nov 05, 2021	SELL	$282.99 - $369.05 $3.66 Million - $4.78 Million	-12,940 Reduced 53.02%	11,465 $3.24 Million
Q2 2021 Aug 06, 2021	BUY	$259.0 - $414.71 $6.32 Million - $10.1 Million	24,405 New	24,405 $8.45 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $2.91 Million - $3.41 Million	-11,998 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$236.26 - $355.63 $2.83 Million - $4.27 Million	11,998 New	11,998 $2.94 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Imc Chicago, LLC, based on Form 13F filings with the SEC.

Stay updated on Imc Chicago, LLC with notifications on news.